BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2036663)

  • 21. A patient-based approach to migraine clinical trials data. An overview.
    Rapoport AM
    Postgrad Med; 2005 May; 117(5 Suppl):3-6. PubMed ID: 19667696
    [No Abstract]   [Full Text] [Related]  

  • 22. Migraine: diagnosis and rational treatment.
    Winner PK
    Int J Fertil Womens Med; 1998; 43(2):104-10. PubMed ID: 9609210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.
    Pryse-Phillips WE; Dodick DW; Edmeads JG; Gawel MJ; Nelson RF; Purdy RA; Robinson G; Stirling D; Worthington I
    CMAJ; 1997 May; 156(9):1273-87. PubMed ID: 9145054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethical problems arising from the use of placebo in clinical trials with drugs for migraine. Their analysis by the moral deliberation method.
    Frías J; Pascual J; Lahuerta J; Gracia D; Dal-Ré R
    Neurologia; 2011 Mar; 26(2):92-9. PubMed ID: 21163201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical consideration influencing experimental design in drug trials for migraine headache therapy.
    Weissman L
    J Clin Pharmacol J New Drugs; 1970; 10(1):50-6. PubMed ID: 4903953
    [No Abstract]   [Full Text] [Related]  

  • 26. Phenotype-driven preventive strategies for migraine and other headaches.
    Wheeler SD
    Neurologist; 2009 Mar; 15(2):59-70. PubMed ID: 19276783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute drug treatment of migraine attack.
    Narbone MC; Abbate M; Gangemi S
    Neurol Sci; 2004 Oct; 25 Suppl 3():S113-8. PubMed ID: 15549517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of migraine attacks and migraine prophylaxis: recommendations of the German Migraine and Headache Society].
    Diener HC; Brune K; Gerber WD; Göbel H; Pfaffenrath V
    Med Monatsschr Pharm; 1998 Feb; 21(2):30-9. PubMed ID: 9531789
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Donaldson D; Sundermann R; Jackson R; Bastani A
    Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches.
    Troost BT
    Expert Rev Neurother; 2004 Jan; 4(1):27-31. PubMed ID: 15853612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory migraine headache controlled with alprazolam: case report.
    Othmer SC; Othmer E; Varanka TM; Strong DM
    J Clin Psychiatry; 1985 Nov; 46(11):494-5. PubMed ID: 3902808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining proof-of-concept with dose-finding: utilization of adaptive designs in migraine clinical trials.
    Sagkriotis A; Scholpp J
    Cephalalgia; 2008 Aug; 28(8):805-12. PubMed ID: 18513264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Migraine--vasomotor headache and its therapeutic approaches].
    Glaser A
    Med Welt; 1974 Sep; 25(36):1435-8. PubMed ID: 4612289
    [No Abstract]   [Full Text] [Related]  

  • 34. Tonabersat, a novel gap-junction modulator for the prevention of migraine.
    Silberstein SD
    Cephalalgia; 2009 Nov; 29 Suppl 2():28-35. PubMed ID: 19723123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractory headache: classification and nomenclature.
    Levin M
    Headache; 2008 Jun; 48(6):783-90. PubMed ID: 18549356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sulpiride in the treatment of migraine, tension headache and associated psychosomatic disorders].
    Hakkarainen H; Viukari M
    Duodecim; 1973 Aug; 89(22):1504-9. PubMed ID: 4587835
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment guidelines for acute migraine attacks].
    Treatment Guideline Subcommittee of Taiwan Headache Society
    Acta Neurol Taiwan; 2007 Dec; 16(4):251-68. PubMed ID: 18220021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rizatriptan in the treatment of migraine.
    Dahlof CG; Rapoport AM; Sheftell FD; Lines CR
    Clin Ther; 1999 Nov; 21(11):1823-36; discussion 1821. PubMed ID: 10890255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators.
    Tfelt-Hansen P; Pascual J; Ramadan N; Dahlöf C; D'Amico D; Diener HC; Hansen JM; Lanteri-Minet M; Loder E; McCrory D; Plancade S; Schwedt T;
    Cephalalgia; 2012 Jan; 32(1):6-38. PubMed ID: 22384463
    [No Abstract]   [Full Text] [Related]  

  • 40. Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition - An experience-based update.
    Abu-Arafeh I; Hershey AD; Diener HC; Tassorelli C
    Cephalalgia; 2023 May; 43(5):3331024231178239. PubMed ID: 37226450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.